Sjoert van der Berg has over 11 year experience in finance, accounting, audit and controlling. He joined AM-Pharma as Finance Director in November 2019.
Prior to joining AM-Pharma, he worked as Associate Director Finance in publicly traded biotech company Genmab. In this role he was responsible for the local accounting of the Dutch entity of the company and controlling of a number of pre-clinical and clinical stage oncology studies.
Before that, he worked at KPMG as an auditor. At KPMG he was auditing large domestic and international clients in different industries. During his work at KPMG he became CPA (Certified Public Accountant).